These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 27671820
1. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs. Prasad R, Katiyar SK. Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820 [Abstract] [Full Text] [Related]
2. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Kumar A, Kumar Singh U, Chaudhary A. Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094 [Abstract] [Full Text] [Related]
3. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Vaid M, Sharma SD, Katiyar SK. Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108 [Abstract] [Full Text] [Related]
4. Honokiol: a novel natural agent for cancer prevention and therapy. Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Curr Mol Med; 2012 Dec; 12(10):1244-52. PubMed ID: 22834827 [Abstract] [Full Text] [Related]
5. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Pharmacol Res; 2019 Jun; 144():192-209. PubMed ID: 31002949 [Abstract] [Full Text] [Related]
6. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor. Singh T, Gupta NA, Xu S, Prasad R, Velu SE, Katiyar SK. Oncotarget; 2015 Aug 28; 6(25):21268-82. PubMed ID: 26020804 [Abstract] [Full Text] [Related]
7. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation. Yamaguchi M, Arbiser JL, Weitzmann MN. Int J Mol Med; 2011 Dec 28; 28(6):1049-53. PubMed ID: 21887456 [Abstract] [Full Text] [Related]
8. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2. Singh T, Katiyar SK. Int J Oncol; 2011 Mar 28; 38(3):769-76. PubMed ID: 21225228 [Abstract] [Full Text] [Related]
9. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J. Oncotarget; 2015 Nov 10; 6(35):37335-48. PubMed ID: 26484567 [Abstract] [Full Text] [Related]
10. Honokiol targets mitochondria to halt cancer progression and metastasis. Pan J, Lee Y, Wang Y, You M. Mol Nutr Food Res; 2016 Jun 10; 60(6):1383-95. PubMed ID: 27276215 [Abstract] [Full Text] [Related]
11. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Saeed M, Kuete V, Kadioglu O, Börtzler J, Khalid H, Greten HJ, Efferth T. Phytomedicine; 2014 Oct 15; 21(12):1525-33. PubMed ID: 25442261 [Abstract] [Full Text] [Related]
12. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Oncotarget; 2016 Sep 06; 7(36):57752-57769. PubMed ID: 27458163 [Abstract] [Full Text] [Related]
13. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Am J Surg; 2014 Dec 06; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590 [Abstract] [Full Text] [Related]
14. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Lu CH, Chen SH, Chang YS, Liu YW, Wu JY, Lim YP, Yu HI, Lee YR. Pharmacol Res; 2017 Jan 06; 115():288-298. PubMed ID: 27940017 [Abstract] [Full Text] [Related]
15. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M. Cancer Prev Res (Phila); 2017 Feb 06; 10(2):133-141. PubMed ID: 27849557 [Abstract] [Full Text] [Related]
16. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. Chen YJ, Tsai KS, Chan DC, Lan KC, Chen CF, Yang RS, Liu SH. J Orthop Res; 2014 Apr 06; 32(4):573-80. PubMed ID: 24375705 [Abstract] [Full Text] [Related]
17. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. Ishikawa C, Arbiser JL, Mori N. Biochim Biophys Acta; 2012 Jul 06; 1820(7):879-87. PubMed ID: 22465179 [Abstract] [Full Text] [Related]
18. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G. J Cell Physiol; 2012 May 06; 227(5):2184-95. PubMed ID: 21792937 [Abstract] [Full Text] [Related]
19. Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol. Pearson HE, Iida M, Orbuch RA, McDaniel NK, Nickel KP, Kimple RJ, Arbiser JL, Wheeler DL. Mol Cancer Ther; 2018 Jan 06; 17(1):204-214. PubMed ID: 29054984 [Abstract] [Full Text] [Related]
20. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Cancer; 2007 Apr 01; 109(7):1279-89. PubMed ID: 17326044 [Abstract] [Full Text] [Related] Page: [Next] [New Search]